A Cross-sectional, Prospective, Observational Study to Evaluate Blood Flow Characteristics in Glaucoma Patients Using Optical Coherence Tomography Based Angiography (OCT-A).

Swiss Vision Network1 site in 1 country200 target enrollmentDecember 31, 2015

ConditionsGlaucoma

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Glaucoma
Sponsor: Swiss Vision Network
Enrollment: 200
Locations: 1
Primary Endpoint: Macular and optic nerve head bloodflow, as measured by OCT-A macular and optic nerve head vessel density (%)
Status: Terminated
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The investigators aim to evaluate the efficacy of the new Optical Coherence Tomography based Angiography (OCT-A) softwares in the diagnosis and management of glaucoma.

Registry

clinicaltrials.gov

Start Date

December 31, 2015

End Date

December 31, 2019

Last Updated

3 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Swiss Vision Network

Responsible Party

Principal Investigator

Dr. Kaweh Mansouri

dr. Kaweh Mansouri

Swiss Vision Network

Eligibility Criteria

Inclusion Criteria

•Diagnosis of open angle glaucoma (OAG) including pseudo-exfoliative and pigmentary glaucoma.
•Documented glaucomatous visual field damage (in the previous 12 months with mean defect (MD) \> 2.0 dB)
•Structural and/or functional glaucomatous damage
•Have given written informed consent, prior to any investigational procedures

Exclusion Criteria

•Patients with allergy to corneal anesthetic
•Patients not able to understand the character and individual consequences of the investigation
•Participation in other clinical research within the last 4 weeks
•Other diseases that may cause visual field loss or optic disc abnormalities
•Refractive error of \> +3.00D or \< -7.00D